Burt Wealth Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Burt Wealth Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-150	Closed	-$2K	–	595
2016 Q1	$2K	Sell	150 -150	-50%	-$2.63K	﹤0.01%	467
2015 Q4	$6K	Sell	300 -200	-40%	-$3.89K	﹤0.01%	354
2015 Q3	$9K	Sell	500 -100	-17%	-$3.16K	0.01%	262
2015 Q2	$21K	Hold	600	–	–	0.02%	205
2015 Q1	$16K	Buy	600 +100	+20%	+$1.83K	0.02%	209
2014 Q4	$6K	Buy	+500	New	+$6.26K	0.01%	271

Other funds holding HZNP

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Burt Wealth Advisors's HZNP Position: Q2 2016 in Review

Burt Wealth Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2016, closing a stake of 150 shares — an estimated $2K sold.

Burt Wealth Advisors first reported a position in HZNP in Q4 2014 and held it in 6 quarters. The position peaked at $21K in Q2 2015. 198 funds tracked by Wall St. Rank hold HZNP as of Q2 2016.

Burt Wealth Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2016 after selling out during the quarter.
Burt Wealth Advisors sold 150 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2016, an estimated $2K.
Burt Wealth Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2014 and held it in 6 quarters.
Burt Wealth Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $21K in Q2 2015.
198 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2016.

Based on Burt Wealth Advisors's 13F filing for Q2 2016, filed 22 Jul 2016.